XRF Scientific's EBIT per Share for the
six
months ended in Dec. 2025 was A$0.05.
Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 was A$0.11.
During the past 12 months, the average EBIT per Share Growth Rate of XRF Scientific was 5.60% per year.
During the past 3 years, the average EBIT per Share Growth Rate was 20.90% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 33.20% per year.
During the past 10 years, the average EBIT per Share Growth Rate was 25.70% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for XRF Scientific's EBIT per Share or its related term are showing as below:
ASX:XRF'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -34.8 Med: 21.25 Max: 65.1
Current: 20.9
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of XRF Scientific was 65.10% per year. The lowest was -34.80% per year. And the median was 21.25% per year.
ASX:XRF's 3-Year EBIT Growth Rate is ranked better than 68.57% of 455
companies
in the Conglomerates industry
Industry Median: 7.4
vs ASX:XRF: 20.90
XRF Scientific's EBIT for the
six
months ended in Dec. 2025 was A$7.54 Mil.
XRF Scientific (ASX:XRF) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
XRF Scientific EBIT per Share Related Terms
XRF Scientific EBIT per Share Historical Data
* Premium members only.
The historical data trend for XRF Scientific's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.11
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XRF Scientific (ASX:XRF) has a EBIT per Share of A$0.11 as of Dec. 2025. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on XRF Scientific and its competitors. According to the industry distribution chart, XRF Scientific ranks #143 out of 455 companies in the Conglomerates industry, placing it in the top 31.4%.
Is XRF Scientific's EBIT per Share too high?
XRF Scientific's current EBIT per Share is A$0.11. Based on the distribution chart, XRF Scientific ranks #143 out of 455 companies in the Conglomerates industry, which is above the industry midpoint. Overall, XRF Scientific has a GF Score™ of 100/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does XRF Scientific's EBIT per Share compare to HON and MMM?
According to the Conglomerates industry distribution chart, XRF Scientific ranks #143 out of 455 companies for EBIT per Share. This puts XRF Scientific in the upper half of its industry. The industry median EBIT per Share is 7.40. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Conglomerates company?
The median EBIT per Share among Conglomerates companies is 7.40, based on 455 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on XRF Scientific and its competitors. For the Conglomerates industry, the median EBIT per Share is 7.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. XRF Scientific's current EBIT per Share is A$0.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is XRF Scientific stock overvalued right now?
Based on GuruFocus' analysis, XRF Scientific (ASX:XRF) is currently considered Fairly Valued. The stock's GF Value™ is A$1.65, compared to a current price of A$1.73 — trading 4.5% above its estimated fair value. The current EBIT per Share is A$0.11. XRF Scientific's overall GF Score™ is 100/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For XRF Scientific (ASX:XRF), the current EBIT per Share is A$0.11 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is XRF Scientific (ASX:XRF) Overvalued in 2026?
Based on GuruFocus' analysis, XRF Scientific stock appears to be overvalued.
The current stock price of A$1.73 is trading 4.5% above its estimated GF Value™ of A$1.65.
GuruFocus considers XRF Scientific to be Fairly Valued.
Key valuation signals for ASX:XRF:
EBIT per Share: A$0.11
GF Value™: A$1.65 vs. price of A$1.73 (4.5% above fair value)
No single metric tells the full story. See the ASX:XRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
XRF Scientific Ltd is engaged in the business of manufacturing and marketing precious metal products, specialized chemicals and instruments for the scientific, analytical and mining industries. It operates through the following segments: Capital Equipment, Precious Metals, and Consumables. The company generates maximum revenue from the Capital Equipment segment that Manufactures sample preparation products and analytical instruments. Geographically, it derives a majority of revenue from Australia and also has a presence in Canada and Europe. Some of its product includes Electric Fusion Machines; Fusion Flux; Crushing and Pulverising, platinum lab ware and others.
100GF Score
Get the complete analysis for ASX:XRF
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:XRF has been successfully added to your 
